Global Naproxen Market Insights, Forecast to 2025

Table of Contents

1 Study Coverage

• 1.1 Naproxen Product
• 1.2 Market Segments
• 1.3 Key Manufacturers Covered
• 1.4 Market by Type
  • 1.4.1 Global Naproxen Market Size Growth Rate by Product
  • 1.4.2 Tablet
  • 1.4.3 Capsule
  • 1.4.4 Other
• 1.5 Market by End User
  • 1.5.1 Global Naproxen Market Size Growth Rate by End User
  • 1.5.2 Rheumatoid Arthritis
  • 1.5.3 Gout
  • 1.5.4 Other
• 1.6 Study Objectives
• 1.7 Years Considered

2 Executive Summary

• 2.1 Global Naproxen Market Size
  • 2.1.1 Global Naproxen Revenue 2014-2025
  • 2.1.2 Global Naproxen Sales 2014-2025
• 2.2 Naproxen Growth Rate by Regions
  • 2.2.1 Global Naproxen Sales by Regions
  • 2.2.2 Global Naproxen Revenue by Regions

3 Breakdown Data by Manufacturers

• 3.1 Naproxen Sales by Manufacturers
  • 3.1.1 Naproxen Sales by Manufacturers
  • 3.1.2 Naproxen Sales Market Share by Manufacturers
  • 3.1.3 Global Naproxen Market Concentration Ratio (CR5 and HHI)
• 3.2 Naproxen Revenue by Manufacturers
  • 3.2.1 Naproxen Revenue by Manufacturers (2014-2019)
  • 3.2.2 Naproxen Revenue Share by Manufacturers (2014-2019)
• 3.3 Naproxen Price by Manufacturers
• 3.4 Naproxen Manufacturing Base Distribution, Product Types
  • 3.4.1 Naproxen Manufacturers Manufacturing Base Distribution, Headquarters
  • 3.4.2 Manufacturers Naproxen Product Type
  • 3.4.3 Date of International Manufacturers Enter into Naproxen Market
• 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product

• 4.1 Global Naproxen Sales by Product
• 4.2 Global Naproxen Revenue by Product
• 4.3 Naproxen Price by Product

5 Breakdown Data by End User

• 5.1 Overview
• 5.2 Global Naproxen Breakdown Data by End User

6 North America

• 6.1 North America Naproxen by Countries
  • 6.1.1 North America Naproxen Sales by Countries
  • 6.1.2 North America Naproxen Revenue by Countries
  • 6.1.3 United States
  • 6.1.4 Canada
  • 6.1.5 Mexico
• 6.2 North America Naproxen by Product
• 6.3 North America Naproxen by End User

7 Europe

• 7.1 Europe Naproxen by Countries
  • 7.1.1 Europe Naproxen Sales by Countries
  • 7.1.2 Europe Naproxen Revenue by Countries
  • 7.1.3 Germany
  • 7.1.4 France
  • 7.1.5 UK
  • 7.1.6 Italy
  • 7.1.7 Russia
• 7.2 Europe Naproxen by Product
• 7.3 Europe Naproxen by End User

8 Asia Pacific

• 8.1 Asia Pacific Naproxen by Countries
  • 8.1.1 Asia Pacific Naproxen Sales by Countries
  • 8.1.2 Asia Pacific Naproxen Revenue by Countries
  • 8.1.3 China
  • 8.1.4 Japan
  • 8.1.5 Korea
  • 8.1.6 India
  • 8.1.7 Australia
  • 8.1.8 Indonesia
  • 8.1.9 Malaysia
  • 8.1.10 Philippines
  • 8.1.11 Thailand
  • 8.1.12 Vietnam
  • 8.1.13 Singapore
• 8.2 Asia Pacific Naproxen by Product
• 8.3 Asia Pacific Naproxen by End User

9 Central & South America

• 9.1 Central & South America Naproxen by Countries
  • 9.1.1 Central & South America Naproxen Sales by Countries
  • 9.1.2 Central & South America Naproxen Revenue by Countries
  • 9.1.3 Brazil
• 9.2 Central & South America Naproxen by Product
• 9.3 Central & South America Naproxen by End User

10 Middle East and Africa

• 10.1 Middle East and Africa Naproxen by Countries
  • 10.1.1 Middle East and Africa Naproxen Sales by Countries
  • 10.1.2 Middle East and Africa Naproxen Revenue by Countries
  • 10.1.3 GCC Countries
  • 10.1.4 Turkey
  • 10.1.5 Egypt
  • 10.1.6 South Africa
• 10.2 Middle East and Africa Naproxen by Product
• 10.3 Middle East and Africa Naproxen by End User

11 Company Profiles

• 11.1 Teva
  • 11.1.1 Teva Company Details
  • 11.1.2 Company Business Overview
  • 11.1.3 Teva Naproxen Sales, Revenue and Gross Margin (2014-2019)
  • 11.1.4 Teva Naproxen Products Offered
  • 11.1.5 Teva Recent Development
• 11.2 Kirsch Pharma GmbH
  • 11.2.1 Kirsch Pharma GmbH Company Details
  • 11.2.2 Company Business Overview
  • 11.2.3 Kirsch Pharma GmbH Naproxen Sales, Revenue and Gross Margin (2014-2019)
  • 11.2.4 Kirsch Pharma GmbH Naproxen Products Offered
  • 11.2.5 Kirsch Pharma GmbH Recent Development
• 11.3 Aurobindo
  • 11.3.1 Aurobindo Company Details
  • 11.3.2 Company Business Overview
  • 11.3.3 Aurobindo Naproxen Sales, Revenue and Gross Margin (2014-2019)
  • 11.3.4 Aurobindo Naproxen Products Offered
  • 11.3.5 Aurobindo Recent Development
• 11.4 Divis Laboratories
  • 11.4.1 Divis Laboratories Company Details
  • 11.4.2 Company Business Overview
  • 11.4.3 Divis Laboratories Naproxen Sales, Revenue and Gross Margin (2014-2019)
  • 11.4.4 Divis Laboratories Naproxen Products Offered
  • 11.4.5 Divis Laboratories Recent Development
• 11.5 Taj Pharmaceuticals Limited
  • 11.5.1 Taj Pharmaceuticals Limited Company Details
  • 11.5.2 Company Business Overview
  • 11.5.3 Taj Pharmaceuticals Limited Naproxen Sales, Revenue and Gross Margin (2014-2019)
  • 11.5.4 Taj Pharmaceuticals Limited Naproxen Products Offered
  • 11.5.5 Taj Pharmaceuticals Limited Recent Development
• 11.6 Tianxin Pharmaceutical
  • 11.6.1 Tianxin Pharmaceutical Company Details
  • 11.6.2 Company Business Overview
  • 11.6.3 Tianxin Pharmaceutical Naproxen Sales, Revenue and Gross Margin (2014-2019)
  • 11.6.4 Tianxin Pharmaceutical Naproxen Products Offered
  • 11.6.5 Tianxin Pharmaceutical Recent Development
• 11.7 Charioteer Pharmaceutical
  • 11.7.1 Charioteer Pharmaceutical Company Details
  • 11.7.2 Company Business Overview
  • 11.7.3 Charioteer Pharmaceutical Naproxen Sales, Revenue and Gross Margin (2014-2019)
  • 11.7.4 Charioteer Pharmaceutical Naproxen Products Offered
  • 11.7.5 Charioteer Pharmaceutical Recent Development
• 11.8 Nhwa Pharmaceutical
  • 11.8.1 Nhwa Pharmaceutical Company Details
  • 11.8.2 Company Business Overview
  • 11.8.3 Nhwa Pharmaceutical Naproxen Sales, Revenue and Gross Margin (2014-2019)
  • 11.8.4 Nhwa Pharmaceutical Naproxen Products Offered
  • 11.8.5 Nhwa Pharmaceutical Recent Development
• 11.9 Huazhong Pharma
  • 11.9.1 Huazhong Pharma Company Details
  • 11.9.2 Company Business Overview
  • 11.9.3 Huazhong Pharma Naproxen Sales, Revenue and Gross Margin (2014-2019)
  • 11.9.4 Huazhong Pharma Naproxen Products Offered
  • 11.9.5 Huazhong Pharma Recent Development

12 Future Forecast

• 12.1 Naproxen Market Forecast by Regions
  • 12.1.1 Global Naproxen Sales Forecast by Regions 2019-2025
  • 12.1.2 Global Naproxen Revenue Forecast by Regions 2019-2025
• 12.2 Naproxen Market Forecast by Product
  • 12.2.1 Global Naproxen Sales Forecast by Product 2019-2025
  • 12.2.2 Global Naproxen Revenue Forecast by Product 2019-2025
• 12.3 Naproxen Market Forecast by End User
• 12.4 North America Naproxen Forecast
• 12.5 Europe Naproxen Forecast
• 12.6 Asia Pacific Naproxen Forecast
• 12.7 Central & South America Naproxen Forecast
• 12.8 Middle East and Africa Naproxen Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

• 13.1 Market Opportunities and Drivers
• 13.2 Market Challenges
• 13.3 Market Risks/Restraints
• 13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis

• 14.1 Value Chain Analysis
• 14.2 Naproxen Customers
• 14.3 Sales Channels Analysis
  • 14.3.1 Sales Channels
  • 14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix

• 16.1 Research Methodology
  • 16.1.1 Methodology/Research Approach
  • 16.1.2 Data Source
• 16.2 Author Details